Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-05-09 07:30 |
Theranexus and BBDF win FDA approval on efficacy endpoints for the Phase III tr…
|
English | 455.6 KB | ||
| 2023-05-09 07:30 |
Theranexus et BBDF obtiennent l'accord de la FDA sur les critères d'efficacité …
|
French | 433.1 KB | ||
| 2023-04-27 07:30 |
MISE A DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2022
|
French | 200.7 KB | ||
| 2023-04-26 17:33 |
URD 2022
|
French | 8.1 MB | ||
| 2023-04-12 18:00 |
THERANEXUS PUBLISHES ITS 2022 FULL-YEAR RESULTS AND PRESENTS AN UPDATE ON ITS P…
|
English | 319.8 KB | ||
| 2023-04-12 18:00 |
THERANEXUS PUBLIE SES RESULTATS ANNUELS 2022 ET FAIT LE POINT SUR SES PROGRAMMES
|
French | 397.9 KB | ||
| 2023-04-04 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 184.6 KB | ||
| 2023-02-20 18:00 |
THERANEXUS, BBDF AND CARDIFF UNIVERSITY PRESENT THEIR NOVEL RESEARCH ON BATTEN-…
|
English | 507.6 KB | ||
| 2023-02-20 18:00 |
THERANEXUS, LA FONDATION BBDF ET L'UNIVERSITÉ DE CARDIFF PRÉSENTENT LEURS NOUVE…
|
French | 495.1 KB | ||
| 2023-02-10 07:30 |
AISTROSIGHT: NEW JOINT PROJECT TEAM BETWEEN THERANEXUS, INRIA, CLAUDE BERNARD U…
|
English | 407.7 KB | ||
| 2023-02-10 07:30 |
AISTROSIGHT : NOUVELLE ÉQUIPE-PROJET COMMUNE ENTRE THERANEXUS, INRIA, L'UNIVERS…
|
French | 400.2 KB | ||
| 2023-01-27 18:00 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ A PORTZAMPARC
|
French | 348.6 KB | ||
| 2023-01-18 07:30 |
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2022 ET ANNONCE UNE …
|
French | 267.6 KB | ||
| 2023-01-18 07:30 |
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2022 AND ANNOUNCES ORG…
|
English | 250.3 KB | ||
| 2023-01-05 18:00 |
Nouvelle avancée pour le Programme Batten-1 de Theranexus et de la fondation BB…
|
French | 451.0 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
